US › Healthcare

Smith & Nephew SNATS Inc (SNN)

US · Healthcare · Medical Devices

$30.44-5.32%
Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue
$3.20B
Revenue YoY
+126.6%
Net profit
$332.0M
Profit YoY
+210.3%
EPS
$0.00
EPS estimate
$0.00
Net margin
10.4%

Key statistics

Market cap
$13.73B
P/E
22.8
Forward P/E
14.5
P/B
2.59
Book value
$2.49
EPS (TTM)
$1.43
Dividend yield
2.40%
52-week high
$37.90
52-week low
$28.56
50-day MA
$30.39
200-day MA
$32.76
Beta
0.68

Analyst view

Analysts rate Smith & Nephew SNATS Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $33.96.

Shareholding

Insiders
0.01%
Institutions
10.11%

Largest institutional holders

FundStake
River Road Asset Management, LLC0.77%
The Goldman Sachs Group Inc0.59%
Bank of Montreal0.53%
BMO Capital Markets Corp.0.53%
LMR Partners LLP0.42%
Todd Asset Management0.33%
Morgan Stanley - Brokerage Accounts0.33%
Brandes Investment Partners & Co0.32%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Smith & Nephew SNATS Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.